Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 2 Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00168779
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 1,185
Post-approval studies (Phase 4)Study completedNCT00403481
What this trial is testing

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

Who this might be right for
Hypertension
Daiichi Sankyo 192
Testing effectiveness (Phase 2)Study completedNCT00374855
What this trial is testing

A Study in People With Mild Hypertension

Who this might be right for
Mild Hypertension
Eli Lilly and Company 153
Testing effectiveness (Phase 2)Ended earlyNCT04053543
What this trial is testing

CXA-10 Study in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
PAH
Complexa, Inc. 33
Large-scale testing (Phase 3)Study completedNCT00353912
What this trial is testing

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

Who this might be right for
Hypertension
Novartis 571
Testing effectiveness (Phase 2)Study completedNCT00779181
What this trial is testing

A Dose-Ranging Study of the Safety and Efficacy of ADX415 in the Treatment of Essential Hypertension

Who this might be right for
Hypertension
Addrenex Pharmaceuticals, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT01302249
What this trial is testing

AR-12286 in Combination With Latanoprost

Who this might be right for
GlaucomaOcular Hypertension
Aerie Pharmaceuticals 66
Early research (Phase 1)UnknownNCT05077462
What this trial is testing

A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

Who this might be right for
Hypertension
AJU Pharm Co., Ltd. 60
Early research (Phase 1)WithdrawnNCT02684786
What this trial is testing

Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension

Who this might be right for
Pulmonary Artery Hypertension
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT05314439
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension

Who this might be right for
Hypertension
Ionis Pharmaceuticals, Inc. 48
Early research (Phase 1)Study completedNCT01523067
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response of Vasomera (PB1046) Injection Following a Single Subcutaneous Dose in Subjects With Stage 1 or 2 Essential Hypertension

Who this might be right for
Essential Hypertension
PhaseBio Pharmaceuticals Inc. 68
Not applicableNot Yet RecruitingNCT06627192
What this trial is testing

Effect of Non-surgical Periodontal Therapy in Hypertensive Patients With Assessment of Endocan and TNF-α Levels in GCF

Who this might be right for
PeriodontitisHypertensionTNF Alpha+2 more
Ain Shams University 40
Testing effectiveness (Phase 2)Study completedNCT00821002
What this trial is testing

Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Mati Therapeutics Inc. 32
Post-approval studies (Phase 4)UnknownNCT03592667
What this trial is testing

Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension

Who this might be right for
Hypertension
University of Guadalajara 20
Testing effectiveness (Phase 2)Study completedNCT03928158
What this trial is testing

LCZ696 in Advanced LV Hypertrophy and HFpEF

Who this might be right for
Heart FailureEssential Hypertension
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 61
Very early researchStudy completedNCT03655704
What this trial is testing

Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study

Who this might be right for
Pulmonary Arterial Hypertension
Steeve Provencher 7
Testing effectiveness (Phase 2)Study completedNCT01528787
What this trial is testing

Study of AR-13324 in Patients With Elevated Intraocular Pressure

Who this might be right for
Ocular HypertensionOpen Angle Glaucoma
Aerie Pharmaceuticals 85
Large-scale testing (Phase 3)Study completedNCT00878917
What this trial is testing

Equivalence Study of Dorzolamide 2% Eye Drops Solution

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Alfred E. Tiefenbacher (GmbH & Co. KG) 32
Testing effectiveness (Phase 2)Study completedNCT00753168
What this trial is testing

Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Othera Pharmaceuticals 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07675824
What this trial is testing

REGN22530 for Adults With Primary Open Angle Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open Angle Glaucoma (POAG)Ocular Hypertension (OHT)
Regeneron Pharmaceuticals 271
Next Page